Literature DB >> 17716190

Sol-gel production of bioactive nanocoatings for medical applications. Part II: current research and development.

Andy H Choi1, Besim Ben-Nissan.   

Abstract

Over the years, the use of hydroxyapatite as coatings for medical devices and drug-delivery systems has gone through a revolution - from being a rarity to being an absolute necessity. Without these coatings, many medical implants and devices would never reach their true potential in their intended applications, such as in the dental and orthopedic fields. Coatings of hydroxyapatite are often applied to metallic implants to alter their surface properties. The aim of this article is to present an evaluation of the published work regarding current research and applications and to review the methods used for the production of hydroxyapatite nanocoatings.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17716190     DOI: 10.2217/17435889.2.1.51

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  4 in total

Review 1.  Evolving application of biomimetic nanostructured hydroxyapatite.

Authors:  Norberto Roveri; Michele Iafisco
Journal:  Nanotechnol Sci Appl       Date:  2010-11-09

2.  Synthesis of hybrid sol-gel materials and their biological evaluation with human mesenchymal stem cells.

Authors:  M Hernández-Escolano; M J Juan-Díaz; M Martínez-Ibáñez; J Suay; I Goñi; M Gurruchaga
Journal:  J Mater Sci Mater Med       Date:  2013-03-09       Impact factor: 3.896

3.  Mechanical compatibility of sol-gel annealing with titanium for orthopaedic prostheses.

Authors:  Andrew I M Greer; Teoh S Lim; Alistair S Brydone; Nikolaj Gadegaard
Journal:  J Mater Sci Mater Med       Date:  2015-12-21       Impact factor: 3.896

4.  First-principles based theoretical calculations of atomic structures of hydroxyapatite surfaces and their charge states in contact with aqueous solutions.

Authors:  T Saito; T Yokoi; A Nakamura; K Matsunaga
Journal:  RSC Adv       Date:  2021-10-20       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.